mifepristone has been researched along with thromboplastin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aigner, S; Krikun, G; Lockwood, CJ; Nemerson, Y; Papp, C; Schatz, F | 1 |
| Demopoulos, R; Guller, S; Krikun, G; Lockwood, CJ; Mackman, N; Schatz, F | 1 |
2 other study(ies) available for mifepristone and thromboplastin
| Article | Year |
|---|---|
Biological mechanisms underlying RU 486 clinical effects: inhibition of endometrial stromal cell tissue factor content.
Topics: Cells, Cultured; Dexamethasone; Endometrium; Estradiol; Female; Gene Expression; Humans; Medroxyprogesterone Acetate; Mifepristone; Progesterone; RNA, Messenger; Thromboplastin | 1994 |
Regulation of tissue factor gene expression in human endometrium by transcription factors Sp1 and Sp3.
Topics: Base Sequence; Cells, Cultured; DNA-Binding Proteins; Early Growth Response Protein 1; Endometrium; Estradiol; Female; Gene Expression Regulation; Hormone Antagonists; Humans; Immediate-Early Proteins; Medroxyprogesterone Acetate; Menstrual Cycle; Mifepristone; Molecular Sequence Data; Progestins; Promoter Regions, Genetic; Recombinant Fusion Proteins; RNA, Messenger; Sp1 Transcription Factor; Sp3 Transcription Factor; Stromal Cells; Thromboplastin; Transcription Factors; Transcription, Genetic | 2000 |